Intratympanic Dexamethasone Injection for Refractory Sudden Sensorineural Hearing Loss
Refractory (planetary science)
Supine position
Regimen
DOI:
10.1097/01.mlg.0000205183.29986.f6
Publication Date:
2006-04-28T10:49:12Z
AUTHORS (4)
ABSTRACT
Abstract Objective: This case‐control study aimed to analyze the effect of intratympanic dexamethasone injection (ITDI) as a treatment option for patients with sudden sensorineural hearing loss (SSNHL) who were refractory classic oral steroid treatment. Methods: Sixty‐six SSNHL, course therapy, included in this study. We prospectively treated consecutive 33 (34 ears) ITDI from August 2002 January 2004. then retrospectively collected data age‐ and sex‐matched previous did not take any more treatments after initial regimen between March 2000 July 2002. was performed supine position on four separate occasions over 2 weeks. Hearing assessed immediately before every at 1 week therapy. improvement defined than 10 dB pure‐tone average (PTA). Results: observed 13 (39.4%) underwent two (6.1%) control group. Five represented 20 PTA, 11 patients, showed no PTA by ITDI, some frequencies. There definite prognostic factors responded those not. Conclusion: may be simple effective therapy SSNHL.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (16)
CITATIONS (84)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....